Floatz logo

Eloxatin

MSS

Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 3Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
81/ 100

Competitive context

14 Active assets in the MSS cohort.

Asset / SponsorPhaseRating
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Cetuximab
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Nivolumab
Pfizer
Phase 2B
Ipilimumab
Pfizer
Phase 2B
Binimetinib
Pfizer
Phase 2B

View all 20 →

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →